As of November 2024, the U.S. stock market is experiencing turbulence, with major indexes recording weekly losses amid a decline in big-tech stocks and ongoing economic uncertainties. In such a volatile environment, investors often look beyond large-cap companies to explore opportunities in smaller or newer firms, where penny stocks—despite their somewhat outdated moniker—remain a relevant area of interest. These stocks can offer intriguing prospects when they are underpinned by solid financial health and potential for long-term growth.
|
Name |
Share Price |
Market Cap |
Financial Health Rating |
|
BAB (OTCPK:BABB) |
$0.8379 |
$6.09M |
★★★★★★ |
|
RLX Technology (NYSE:RLX) |
$1.69 |
$2.15B |
★★★★★★ |
|
Golden Growers Cooperative (OTCPK:GGRO.U) |
$4.50 |
$69.71M |
★★★★★★ |
|
QuantaSing Group (NasdaqGM:QSG) |
$3.08 |
$143.12M |
★★★★★★ |
|
So-Young International (NasdaqGM:SY) |
$1.25 |
$90.58M |
★★★★☆☆ |
|
LexinFintech Holdings (NasdaqGS:LX) |
$3.22 |
$529.41M |
★★★★★★ |
|
Greenland Technologies Holding (NasdaqCM:GTEC) |
$2.20 |
$29.91M |
★★★★★★ |
|
PHX Minerals (NYSE:PHX) |
$3.71 |
$139.05M |
★★★★★☆ |
|
CBAK Energy Technology (NasdaqCM:CBAT) |
$0.942 |
$84.72M |
★★★★★☆ |
|
Zynerba Pharmaceuticals (NasdaqCM:ZYNE) |
$1.30 |
$65.6M |
★★★★★☆ |
Click here to see the full list of 747 stocks from our US Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Crown Crafts, Inc., with a market cap of $47.14 million, operates in the consumer products industry through its subsidiaries, serving both the United States and international markets.
Operations: The company has not reported any specific revenue segments.
Market Cap: $47.14M
Crown Crafts, Inc., with a market cap of US$47.14 million, faces challenges typical of penny stocks, such as low return on equity (6.4%) and declining net profit margins (3.7% from 5.3% last year). Despite this, its short-term assets exceed both short and long-term liabilities, indicating financial stability. The company’s debt is well covered by operating cash flow (42.2%), although the debt-to-equity ratio has increased to 40.8%. Recent earnings show a decline in net income compared to the previous year but maintain stable revenue figures around US$24 million for Q2 2024.
-
Jump into the full analysis health report here for a deeper understanding of Crown Crafts.
-
Review our historical performance report to gain insights into Crown Crafts’ track record.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle company operating in the United States and internationally, with a market cap of approximately $835.47 million.